Asked by: Al Pinkerton (Liberal Democrat - Surrey Heath)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he is taking to tackle the sale of illegal vapes in Surrey Heath constituency.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The Tobacco and Vapes Bill will strengthen the enforcement of vape sales regulations by giving Ministers in England, Wales, and Northern Ireland the ability to introduce a licensing scheme for the retail sale of tobacco, vapes and nicotine products. The licensing scheme will support Trading Standards to crack down on rogue vape retailers. The Bill also enables the introduction of a new registration scheme for tobacco, vape and nicotine products sold on the United Kingdom market. This will help ensure products are compliant with product safety and standards requirements and will enable Trading Standards to remove non-compliant products from the market quickly and efficiently.
In 2025/26, we will invest £10 million of new funding in Trading Standards to enhance their work to tackle the illicit and underage sale of tobacco and vapes, and support the implementation of the Tobacco and Vapes Bill.
The introduction of a new Vaping Products Duty in October 2026 will provide civil and criminal powers for HM Revenue and Customs to assess for duty and seize products and equipment used to produce or transport illicit vape products.
Asked by: Al Pinkerton (Liberal Democrat - Surrey Heath)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he is taking to help ensure that healthcare services can (a) recruit and (b) retain doctors in Surrey Heath constituency.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
Decisions about recruitment are matters for individual National Health Service employers. NHS trusts manage their recruitment at a local level ensuring they have the right number of staff in place, with the right skill mix, to deliver safe and effective care.
NHS England’s Enhancing Resident Doctors Working Lives programme continues to implement several measures aimed at supporting resident doctors, supporting them to stay in training and the NHS, and reducing overall attrition. In addition, the NHS National Retention Programme is actively improving working conditions for doctors by enhancing workplace culture, promoting flexible training, and reducing burnout and attrition.
Asked by: Al Pinkerton (Liberal Democrat - Surrey Heath)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment he has made of the adequacy of his Department's (a) support for and (b) treatment of people with postural tachycardia syndrome in Surrey Heath constituency.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
Improving health outcomes for people who live with long-term conditions, including postural tachycardia syndrome, is a key part of the Government's mission to build a National Health Service fit for the future. The National Institute for Health and Care Excellence (NICE) publishes guidance on the diagnosis and treatment of long-term conditions for use by healthcare professionals and commissioners. The NICE has produced a clinical knowledge summary on the clinical management of blackouts and syncope, which sets out how clinicians should assess and diagnose postural tachycardia syndrome. This was last updated in November 2023, and is available at the following link:
https://cks.nice.org.uk/topics/blackouts-syncope/diagnosis/assessment/.
Integrated care boards (ICBs) are responsible for commissioning services that meet the needs of their population, and the Government expects ICBs to take account of NICE guidelines and other best practice when designing their local services.
Asked by: Al Pinkerton (Liberal Democrat - Surrey Heath)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment he has made of the adequacy of his Department's (a) support for and (b) treatment of ADHD in Surrey Heath constituency.
Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)
It is the responsibility of the integrated care boards (ICBs) in England to make appropriate provision to meet the health and care needs of their local population, including attention deficit hyperactivity disorder (ADHD) assessments, in line with the relevant National Institute for Health and Care Excellence guidelines.
The Department is supporting a taskforce that NHS England has established to look at ADHD service provision and its impact on patient experience. The taskforce is bringing together expertise from across a broad range of sectors, including the National Health Service, education, and justice, to better understand the challenges affecting people with ADHD, including timely access to services and support.
In conjunction with the taskforce, NHS England has carried out detailed work to develop a data improvement plan, understand the provider and commissioning landscapes, and capture examples from ICBs who are trialling innovative ways of delivering ADHD services.
Asked by: Al Pinkerton (Liberal Democrat - Surrey Heath)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he has taken to reduce waiting times for ADHD assessments in Surrey Heath constituency.
Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)
It is the responsibility of the integrated care boards (ICBs) in England to make appropriate provision to meet the health and care needs of their local population, including attention deficit hyperactivity disorder (ADHD) assessments, in line with the relevant National Institute for Health and Care Excellence guidelines.
The Department is supporting a taskforce that NHS England has established to look at ADHD service provision and its impact on patient experience. The taskforce is bringing together expertise from across a broad range of sectors, including the National Health Service, education, and justice, to better understand the challenges affecting people with ADHD, including timely access to services and support.
In conjunction with the taskforce, NHS England has carried out detailed work to develop a data improvement plan, understand the provider and commissioning landscapes, and capture examples from ICBs who are trialling innovative ways of delivering ADHD services.
Asked by: Al Pinkerton (Liberal Democrat - Surrey Heath)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether his Department has provided funding for the development of (a) more precise and (b) faster diagnostic methods for low grade brain tumours.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The Department recognises that brain cancer patients are often waiting too long for diagnosis. We are determined to change that, which is why we are developing a National Cancer Plan which will seek to improve every aspect of cancer care and the experience and outcomes for people with cancer, including brain cancer. Although low-grade brain tumours are non-cancerous, they can have similar, serious symptoms and require surgery or radiotherapy to treat them. The Department welcomes submissions on brain tumours to the new online platform, Shaping the national cancer plan. Further information is available at the following link:
https://www.gov.uk/government/calls-for-evidence/shaping-the-national-cancer-plan
In the five years between 2018/19 and 2022/23, the National Institute for Health and Care Research (NIHR) directly invested £11.3 million in research projects and programmes focused on brain tumours, including low grade brain tumours. In addition, our wider investments in NIHR research infrastructure, which includes facilities, services, and the research workforce, are estimated to be £31.5 million, between 2018/19 and 2022/23, and have enabled 227 brain cancer research studies to take place in the same period. In total, NIHR investments have enabled 8,500 people to participate in potentially life-changing research in the National Health Service over this time.
In September 2024, the NIHR announced new research funding opportunities for brain cancer research, spanning both adult and paediatric populations. This includes a national NIHR Brain Tumour Research Consortium, to ensure that the most promising research opportunities are made available to adult and child patients, and a new funding call to generate high quality evidence in brain tumour care, support, and rehabilitation.
The NIHR welcomes funding applications for research into any aspect of human health, including low grade brain tumours. Applications are subject to peer review and judged in open competition, with awards being made on the basis of the importance of the topic to patients and health and care services, value for money, and scientific quality.
Asked by: Al Pinkerton (Liberal Democrat - Surrey Heath)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what funding his Department is making into new treatment research and innovation for low grade brain treatments.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The Department recognises that brain cancer patients are often waiting too long for diagnosis. We are determined to change that, which is why we are developing a National Cancer Plan which will seek to improve every aspect of cancer care and the experience and outcomes for people with cancer, including brain cancer. Although low-grade brain tumours are non-cancerous, they can have similar, serious symptoms and require surgery or radiotherapy to treat them. The Department welcomes submissions on brain tumours to the new online platform, Shaping the national cancer plan. Further information is available at the following link:
https://www.gov.uk/government/calls-for-evidence/shaping-the-national-cancer-plan
In the five years between 2018/19 and 2022/23, the National Institute for Health and Care Research (NIHR) directly invested £11.3 million in research projects and programmes focused on brain tumours, including low grade brain tumours. In addition, our wider investments in NIHR research infrastructure, which includes facilities, services, and the research workforce, are estimated to be £31.5 million, between 2018/19 and 2022/23, and have enabled 227 brain cancer research studies to take place in the same period. In total, NIHR investments have enabled 8,500 people to participate in potentially life-changing research in the National Health Service over this time.
In September 2024, the NIHR announced new research funding opportunities for brain cancer research, spanning both adult and paediatric populations. This includes a national NIHR Brain Tumour Research Consortium, to ensure that the most promising research opportunities are made available to adult and child patients, and a new funding call to generate high quality evidence in brain tumour care, support, and rehabilitation.
The NIHR welcomes funding applications for research into any aspect of human health, including low grade brain tumours. Applications are subject to peer review and judged in open competition, with awards being made on the basis of the importance of the topic to patients and health and care services, value for money, and scientific quality.
Asked by: Al Pinkerton (Liberal Democrat - Surrey Heath)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how the (a) 10-Year Health Plan and (b) Cancer Plan will ensure that the specific needs of people living with low grade brain tumours are properly recognised and supported.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The Department recognises that brain cancer patients are often waiting too long for diagnosis. We are determined to change that, which is why we are developing a National Cancer Plan which will seek to improve every aspect of cancer care and the experience and outcomes for people with cancer, including brain cancer. Although low-grade brain tumours are non-cancerous, they can have similar, serious symptoms and require surgery or radiotherapy to treat them. The Department welcomes submissions on brain tumours to the new online platform, Shaping the national cancer plan. Further information is available at the following link:
https://www.gov.uk/government/calls-for-evidence/shaping-the-national-cancer-plan
In the five years between 2018/19 and 2022/23, the National Institute for Health and Care Research (NIHR) directly invested £11.3 million in research projects and programmes focused on brain tumours, including low grade brain tumours. In addition, our wider investments in NIHR research infrastructure, which includes facilities, services, and the research workforce, are estimated to be £31.5 million, between 2018/19 and 2022/23, and have enabled 227 brain cancer research studies to take place in the same period. In total, NIHR investments have enabled 8,500 people to participate in potentially life-changing research in the National Health Service over this time.
In September 2024, the NIHR announced new research funding opportunities for brain cancer research, spanning both adult and paediatric populations. This includes a national NIHR Brain Tumour Research Consortium, to ensure that the most promising research opportunities are made available to adult and child patients, and a new funding call to generate high quality evidence in brain tumour care, support, and rehabilitation.
The NIHR welcomes funding applications for research into any aspect of human health, including low grade brain tumours. Applications are subject to peer review and judged in open competition, with awards being made on the basis of the importance of the topic to patients and health and care services, value for money, and scientific quality.
Asked by: Al Pinkerton (Liberal Democrat - Surrey Heath)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment he has made of the adequacy of support available for people impacted by (a) pelvic mesh and (b) sodium valproate in Surrey.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
Our sympathies remain with those affected by sodium valproate and pelvic mesh.
There are nine specialist mesh centres across England, to ensure that women in every region with complications of mesh inserted for urinary incontinence and vaginal prolapse get the right support. Each mesh centre is led by a multi-disciplinary team to ensure patients get access to the specialist care and treatment that they need, including pain management and psychological support. In the South East region, the mesh centre is located at University Hospital Southampton NHS Foundation Trust; however patients can ask to be referred to any of the nine mesh centres.
Significant action has been taken to strengthen oversight of valproate prescribing. Valproate must now not be started in new patients, male or female, younger than 55 years old unless two specialists independently consider and document that there is no other effective or tolerated treatment, or there are compelling reasons that the reproductive risks do not apply.
The Government is carefully considering the work done by the Patient Safety Commissioner and the resulting Hughes Report. The report sets out options for redress for those harmed by sodium valproate and pelvic mesh. The Government will be providing an update to the Patient Safety Commissioner’s Report at the earliest opportunity.
Asked by: Al Pinkerton (Liberal Democrat - Surrey Heath)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that hospitals can (a) recruit and (b) retain midwives in Surrey Heath constituency.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
The Government is committed to tackling the retention and recruitment challenges that face the National Health Service. Bringing in the staff we need will take time, but this is an absolute priority for the Government. NHS England is leading a range of initiatives to boost retention of existing staff and ensure that the NHS remains an attractive career choice for new recruits. This includes building a compassionate and inclusive culture, supporting staff wellbeing, and promoting flexible working opportunities.
Targeted retention work for midwives is being undertaken by NHS England, led by the Chief Nursing Officer. This work contains a range of measures, including the creation of a midwifery and nursing retention self-assessment tool, mentoring schemes, strengthened advice and support on pensions, and embedded flexible retirement options. NHS England has also invested in unit-based retention leads which, alongside investment in workforce capacity, has seen a reduction in vacancy, leaver, and turnover rates.
The Frimley Health midwifery workforce, which includes the Surrey Heath area, now has in place a fully resourced midwifery workforce. This follows five-years of work, led by the trust, on recruitment and retention, in addition to the ongoing work by NHS England.